SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kwality Pharmaceuticals informs about press release

20 Feb 2026 Evaluate
Kwality Pharmaceuticals has informed that it enclosed copy of the Newspaper Publication of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31, 2025 published in the newspaper, Financial Express (English) and Punjabi Jagran (Punjabi) on February 14, 2026.

The above information is a part of company’s filings submitted to BSE.

Kwality Pharma Share Price

1687.00 -64.25 (-3.67%)
11-May-2026 10:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1863.90
Dr. Reddys Lab 1279.75
Cipla 1338.65
Zydus Lifesciences 935.55
Lupin 2250.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×